COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 2713: Articles 27121-27130  | Next

A Modular Microarray Imaging System for Highly Specific COVID-19 Antibody Testing
Hedde, P. N., Abram, T. J., Jain, A., Nakajima, R., Ramiro de Assis, R., Pearce, T., Jasinskas, A., Toosky, M. N., Khan, S., Felgner, P. L., Gratton, E., Zhao, W.
10.1101/2020.05.22.111518 — Posted: 2020-05-23
Predicting wildlife hosts of betacoronaviruses for SARS-CoV-2 sampling prioritization
Becker, D., Albery, G. F., Sjodin, A. R., Poisot, T., Dallas, T., Eskew, E. A., Farrell, M. J., Guth, S., Han, B. A., Simmons, N. B., Carlson, C. J.
10.1101/2020.05.22.111344 — Posted: 2020-05-23 Discussion: Offsite
Age-related expression of SARS-CoV-2 priming protease TMPRSS2 in the developing lung
Schuler, B. A., Habermann, A. C., Plosa, E. J., Taylor, C. J., Jetter, C. S., Kapp, M. E., Benjamin, J., Gulleman, P., Nichols, D. S., Braunstein, L. Z., Koval, M. H., Guttentag, S. H., Blackwell, T. S., Vanderbilt COVID-19 Consortium Cohort, , Webber, S. A., Banovich, N., Kropski, J. A., Sucre, J. M., HCA Lung Biological Network
10.1101/2020.05.22.111187 — Posted: 2020-05-23
Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19
Cervia, C., Nilsson, J., Zurbuchen, Y., Valaperti, A., Schreiner, J., Wolfensberger, A., Raeber, M. E., Adamo, S., Emmenegger, M., Hasler, S., Bosshard, P. P., De Cecco, E., Baechli, E., Rudiger, A., Stuessi-Helbling, M., Huber, L. C., Zinkernagel, A. S., Schaer, D. J., Aguzzi, A., Held, U., Probst-Mueller, E., Rampini, S. K., Boyman, O.
10.1101/2020.05.21.108308 — Posted: 2020-05-23 Discussion: Onsite | Offsite
Methods of inactivation of SARS-CoV-2 for downstream biological assays
Patterson, E. I., Prince, T., Anderson, E. R., Casas-Sanchez, A., Smith, S. L., Cansado-Utrilla, C., Turtle, L., Hughes, G. L.
10.1101/2020.05.21.108035 — Posted: 2020-05-23
A pandemic at the Tunisian scale. Mathematical modelling of reported and unreported COVID-19 infected cases
Abdeljaoued-Tej, I.
10.1101/2020.05.21.20108621 — Posted: 2020-05-23
The Challenge of Using Epidemiological Case Count Data: The Example of Confirmed COVID-19 Cases and the Weather
Cohen, F., Schwarz, M., Li, S., Lu, Y., Jani, A.
10.1101/2020.05.21.20108803 — Posted: 2020-05-23
Forecasting trajectories of an emerging epidemic with mathematical modeling in an online dashboard: The case of COVID-19
Młocek, W., Lew, R.
10.1101/2020.05.21.20108753 — Posted: 2020-05-23
Improved measurement of racial/ethnic disparities in COVID-19 mortality in the United States
Goldstein, J. R., Atherwood, S.
10.1101/2020.05.21.20109116 — Posted: 2020-05-23
A score-based risk model for predicting severe COVID-19 infection as a key component of lockdown exit strategy
Dagan, N., Barda, N., Riesel, D., Grotto, I., Sadetzki, S., Balicer, R.
10.1101/2020.05.20.20108571 — Posted: 2020-05-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).